Brief: Alkem Labs Says US FDA Issues Form 483 With 6 Procedural Observations
16/02/2026 10:24
Feb 16 (Reuters) - Alkem Laboratories Ltd ALKE.NS: ALKEM LABS - USFDA ISSUES FORM 483 WITH 6 PROCEDURAL OBSERVATIONS ALKEM LABS - USFDA INSPECTION AT MANUFACTURING FACILITY OF ENZENE BIOSCIENCES Source text: ID:nBSE6BrxyZ Further company coverage: ALKE.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Alkem Laboratories
See all newsBrief: Alkem Labs Approved Initiation Of Forensic Audit In Connection With Recent Incident Involving Alleged Misappropriation Of Funds By A Former Employee
Brief: Alkem Labs Launches Neuceno (Cenobamate) For Treatment Of Partial-Onset Seizures In Adult Patients
Brief: Alkem Labs Launches Renocia Exo, Ginsenoside Exosome-Based Hair Growth Serum
Brief: Alkem Labs Board Approves Investment Of Up To 750 Million Rupees For New Block At Baddi Manufacturing Facility
Brief: Alkem Laboratories Q1 Consol Revenue From Operations 37.4 Billion Rupees